Barbara Brooks-Worrell1, Jerry P Palmer. 1. Department of Medicine, DVA Puget Sound Health Care System, Seattle, WA 98108, USA. bbrooks@u.washington.edu
Abstract
BACKGROUND: Diabetes mellitus has been historically divided into type 1 and type 2 diabetes, with type 1 being an autoimmune disease and type 2 being primarily a metabolic disease. CONTENT: The current diabetes classification scheme needs to be reevaluated because of the accumulating evidence of immune system involvement in the pathophysiology of type 2 diabetes. SUMMARY: There are similarities and differences between type 1 and type 2 diabetes with regard to pathogenesis, pathophysiology, and genetics. We propose a resolution to the dilemma of the current classification scheme.
BACKGROUND:Diabetes mellitus has been historically divided into type 1 and type 2 diabetes, with type 1 being an autoimmune disease and type 2 being primarily a metabolic disease. CONTENT: The current diabetes classification scheme needs to be reevaluated because of the accumulating evidence of immune system involvement in the pathophysiology of type 2 diabetes. SUMMARY: There are similarities and differences between type 1 and type 2 diabetes with regard to pathogenesis, pathophysiology, and genetics. We propose a resolution to the dilemma of the current classification scheme.
Authors: Gerard A Bouland; Joline W J Beulens; Joey Nap; Arno R van der Slik; Arnaud Zaldumbide; Leen M 't Hart; Roderick C Slieker Journal: BMC Genomics Date: 2022-05-14 Impact factor: 4.547
Authors: Marguerite R Irvin; Nathan E Wineinger; Treva K Rice; Nicholas M Pajewski; Edmond K Kabagambe; Charles C Gu; Jim Pankow; Kari E North; Jemma B Wilk; Barry I Freedman; Nora Franceschini; Uli Broeckel; Hemant K Tiwari; Donna K Arnett Journal: PLoS One Date: 2011-08-25 Impact factor: 3.240
Authors: Barbara M Brooks-Worrell; Ashley H Tjaden; Sharon L Edelstein; Brenda Palomino; Kristina M Utzschneider; Silva Arslanian; Kieren J Mather; Thomas A Buchanan; Kristen J Nadeau; Karen Atkinson; Elena Barengolts; Steven E Kahn; Jerry P Palmer Journal: Front Immunol Date: 2021-04-26 Impact factor: 7.561